MoneyWorks4Me

Eiko Lifesciences - Quaterly Results

08 Feb 2022 Evaluate
The revenue for the December 2021 quarter is pegged at Rs. 55.80 millions against Rs. 58.46 millions recorded during the year-ago period.The Net Loss for the quarter ended December 2021 is Rs. -0.60 millions as compared to Net Profit of Rs. 2.08 millions of corresponding quarter ended December 2020A decline of 2.02 millions was observed in the OP in the quarter ended December 2021 from 3.13 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 55.80 58.46 -4.55 201.19 59.16 240.08 119.91 0.00 0.00
Other Income 1.47 1.22 20.49 4.67 2.44 91.39 4.60 4.30 6.98
PBIDT 2.02 3.13 -35.46 15.16 4.28 254.21 9.83 2.61 276.63
Interest 1.27 0.21 504.76 3.59 0.33 987.88 0.88 0.68 29.41
PBDT 0.75 2.92 -74.32 11.57 3.95 192.91 8.95 1.93 363.73
Depreciation 1.53 0.15 920.00 4.07 0.45 804.44 0.62 0.62 0.00
PBT -0.78 2.77 -128.16 7.50 3.50 114.29 8.33 1.31 535.88
TAX -0.18 0.69 -126.09 1.91 0.84 127.38 2.18 0.02 10800.00
Deferred Tax 0.58 -0.01 -5900.00 1.88 -0.02 -9500.00 -0.03 -0.20 -85.00
PAT -0.60 2.08 -128.85 5.59 2.66 110.15 6.15 1.29 376.74
Equity 83.16 38.20 117.70 83.16 38.20 117.70 38.20 38.20 0.00
PBIDTM(%) 3.62 5.35 -32.39 7.54 7.23 4.16 8.20 0.00 0.00
Peers
Company Name CMP
Godrej Industries 1021.20
SRF 2490.00
BASF India 3411.40
Pidilite Inds. 1470.00
Tata Chemicals 607.90
View more..